Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 2
1950 2
1952 1
1956 2
1960 1
1963 1
1964 9
1965 8
1966 11
1967 7
1968 3
1969 4
1970 5
1971 2
1972 13
1973 8
1974 10
1975 8
1976 7
1977 3
1978 9
1979 13
1980 8
1981 6
1982 4
1983 3
1984 5
1985 6
1986 7
1987 6
1988 4
1989 6
1990 2
1991 6
1992 4
1993 5
1994 2
1995 2
1996 1
1997 4
1998 2
1999 2
2000 4
2001 2
2002 3
2003 3
2004 4
2005 2
2006 5
2007 1
2008 2
2009 1
2010 4
2011 2
2012 2
2013 3
2014 2
2015 2
2016 3
2017 1
2018 5
2019 4
2020 11
2021 4
2022 13
2023 15
2024 7
2025 2
2026 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

313 results

Results by year

Filters applied: . Clear all
Page 1
Tolnaftate.
[No authors listed] [No authors listed] 2024 Nov 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. 2024 Nov 15. Drugs and Lactation Database (LactMed®) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006–. PMID: 30000499 Free Books & Documents. Review.
Topical tolnaftate has not been studied during breastfeeding and no data are available on the extent of its absorption after topical application. ...
Topical tolnaftate has not been studied during breastfeeding and no data are available on the extent of its absorption after topical …
Tinea pedis: an updated review.
Leung AK, Barankin B, Lam JM, Leong KF, Hon KL. Leung AK, et al. Drugs Context. 2023 Jun 29;12:2023-5-1. doi: 10.7573/dic.2023-5-1. eCollection 2023. Drugs Context. 2023. PMID: 37415917 Free PMC article. Review.
Examples of topical antifungal agents include allylamines (e.g. terbinafine), azoles (e.g. ketoconazole), benzylamine, ciclopirox, tolnaftate and amorolfine. Oral antifungal agents used for the treatment of tinea pedis include terbinafine, itraconazole and fluconazole. ...
Examples of topical antifungal agents include allylamines (e.g. terbinafine), azoles (e.g. ketoconazole), benzylamine, ciclopirox, tolnaf …
Otomycosis: Diagnosis and treatment.
Vennewald I, Klemm E. Vennewald I, et al. Clin Dermatol. 2010 Mar 4;28(2):202-11. doi: 10.1016/j.clindermatol.2009.12.003. Clin Dermatol. 2010. PMID: 20347664 Review.
Topical antifungals, such as clotrimazole, miconazole, bifonazole, ciclopiroxolamine, and tolnaftate, are potentially safe choices for the treatment of otomycosis, especially in patients with a perforated eardrum. ...
Topical antifungals, such as clotrimazole, miconazole, bifonazole, ciclopiroxolamine, and tolnaftate, are potentially safe choices fo …
Tolnaftate inhibits ergosterol production and impacts cell viability of Leishmania sp.
Yamamoto ES, de Jesus JA, Bezerra-Souza A, Brito JR, Lago JHG, Laurenti MD, Passero LFD. Yamamoto ES, et al. Bioorg Chem. 2020 Sep;102:104056. doi: 10.1016/j.bioorg.2020.104056. Epub 2020 Jul 2. Bioorg Chem. 2020. PMID: 32653607
Tolnaftate eliminated promastigote forms of L. (L.) amazonensis, L. (V.) braziliensis and L. ...(L.) amazonensis treated with the EC(50) of tolnaftate displayed morphological and physiological changes in the mitochondria and cell membrane. ...
Tolnaftate eliminated promastigote forms of L. (L.) amazonensis, L. (V.) braziliensis and L. ...(L.) amazonensis treated with the EC( …
Tolnaftate.
[No authors listed] [No authors listed] Br Med J. 1967 Sep 23;3(5568):785. Br Med J. 1967. PMID: 6039652 Free PMC article. No abstract available.
Butenafine.
McNeely W, Spencer CM. McNeely W, et al. Drugs. 1998 Mar;55(3):405-12; discussion 413. doi: 10.2165/00003495-199855030-00006. Drugs. 1998. PMID: 9530545 Review.
In vitro, the minimum concentration that completely inhibited growth of dermatophytes (MIC) and the minimum fungicidal concentrations (MFC) for butenafine against T. mentagrophytes and M. canis were similar (0.012 to 0.05 mg/L) and were 4 to 130 times lower than those for naftifi …
In vitro, the minimum concentration that completely inhibited growth of dermatophytes (MIC) and the minimum fungicidal concentrations (MFC) …
Tolnaftate, a potent topical antifungal agent.
Robinson HM Jr, Raskin J. Robinson HM Jr, et al. Arch Dermatol. 1965 Apr;91(4):372-6. doi: 10.1001/archderm.91.4.372. Arch Dermatol. 1965. PMID: 9626090 Clinical Trial. No abstract available.
Superficial mycoses.
Taplin D. Taplin D. J Invest Dermatol. 1976 Jul;67(1):177-81. doi: 10.1111/1523-1747.ep12513020. J Invest Dermatol. 1976. PMID: 778288 Free article. Review.
The introduction of topical nystatin for candidiasis and tolnaftate for dermatophytosis were major advances, but tinea capitis, onychomycosis, and chronic tinea pedis still presented problems. ...
The introduction of topical nystatin for candidiasis and tolnaftate for dermatophytosis were major advances, but tinea capitis, onych …
Tolnaftate powder in prophylaxis of tinea pedis.
Smith EB, Dickson JE, Knox JM. Smith EB, et al. South Med J. 1974 Jul;67(7):776-8. doi: 10.1097/00007611-197407000-00008. South Med J. 1974. PMID: 4600407 Clinical Trial. No abstract available.
313 results